Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators and their colleagues.
Mayo Clinic Platform Unveils Solutions Studio to Propel Digital Health Innovation
What You Should Know: – Mayo Clinic Platform launches Solutions Studio, a groundbreaking program designed to accelerate the development, validation, and deployment of digital health
March 16, 2024